Hyperglycemia in the Perioperative Period of Liver Transplantation: A Scoping Review
Keywords:
Hyperglycemia, Liver Transplantation, Glycemic ControlAbstract
Objective: To find evidence on the influence of hyperglycaemia in the perioperative period of liver transplantation. Methodology: This is a scoping review of the PubMed, VHL and Web Of Science databases. The following descriptors were used: ‘Liver transplantation’, ‘Hyperglycemia’ and ‘Blood Sugar Control’ with the Boolean operator ‘AND’, and articles of relevance to the topic were selected. Initially, 139 articles were selected, all published in the last 20 years, in Portuguese and English. After analysis, 10 articles corresponded to the proposed objective. Results: In the comparison between strict control and conventional glucose control in patients undergoing liver transplantation, the average intraoperative glycaemia was 143.3 mg/dL in the conventional group and 130.7 mg/dL in the strict control group, which received more insulin. The intensive care unit stay was similar with a mean of 3 days, but survival improved significantly with mean intraoperative glycaemia ≤120 mg/dL. Patients with post reperfusion syndrome required insulin infusion more often. New-onset diabetes mellitus and early bacteraemia were more frequent in the post-reperfusion syndrome group. AST and ALT levels were higher in hyperglycaemic patients. Surgical site infection rates correlated with postoperative hyperglycaemia, with 20% for glycaemia <200 mg/dL and 52% for glycaemia ≥200 mg/dL. Patients with postoperative glucose <200 mg/dL had a lower rejection rate compared to those with glucose ≥200 mg/dL. Diabetics had higher preoperative glycaemia than non-diabetics, with a gradual reduction after liver transplantation, while non-diabetics had a peak on days 2 and 3 before returning to baseline levels. High glucose levels 48-72 hours post-transplant were associated with higher mortality and a worse response to insulin treatment in the first week. Conclusion: Strict glycaemic control in patients undergoing liver transplantation resulted in lower intraoperative glycaemia and significantly better survival for those with glycaemia ≤120 mg/dL, as well as lower rates of infection, rejection and mortality, especially in non-diabetics.
Downloads
References
1. Duan Y, Li ZZ, Liu P, Cui L, Gao Z, Zhang H. The efficacy of intraoperatie continuous glucose monitoring in patients undergoing liver transplantation: a study protocol for a prospective randomized controlled superiority trial. Trials 2023; 24(1):72. https://doi.org/10.1186/s13063-023-07073-x
2. Kumar SS, Pelletier SJ, Shanks A, Thompson A, Sonnenday CJ, Picton P. Intraoperative glycemic control in patients undergoing Orthotopic liver transplant: a single center prospective randomized study. BMC Anesthesiol 2020; 20:3. https://doi.org/10.1186/s12871-019-0918-0
3. Chae S, Choi J, Lim S, Choi HJ, Park J, Hong SH, et al. Stress burden related to postreperfusion syndrome may aggravate hyperglycemia with insulin resistance during living donor liver transplantation: A propensity score-matching analysis. PLoS ONE 2020; 15(12): e0243873. https://doi.org/10.1371/journal.pone.0243873
4. Bragança ACC, Álvares-da-Silva MR. Prevalence of diabetes mellitus and impaired glucose tolerance in patients with decompensated cirrhosis being evaluated for liver transplantation: the utility of oral glucose tolerance test. Arq Gastroenterol 2010; 47(1): 22-7. https://doi.org/10.1590/S0004-28032010000100005
5. García-Compean D, Jaquez-Quintana JO, Maldonado-Garza H. Hepatogenous diabetes. Current views of an ancient problem. Ann Hepatol 2009; 8(1):1 3-20. https://doi.org/10.1016/S1665-2681(19)31805-8
6. Park CS. Predictive roles of intraoperative blood glucose for post-transplant outcomes in liver transplantation. World J Gastroenterol 2015; 21(22): 6835-41. https://doi.org/10.3748/wjg.v21.i22.6835
7. Paka P, Lieber SR, Lee RA, Desai CS, Dupuis RE, Barritt AS. Perioperative glucose management and outcomes in liver transplant recipients: A qualitative systematic review. World J Transplant 2018; 8(3): 75-83. https://doi.org/10.5500/wjt.v8.i3.75
8. JBI Manual for Evidence Synthesis - JBI Global Wiki [citado em 2024 Abr 2]. Disponível em: https://jbi global-wiki.refined.site/space/MANUAL
9. Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMAScR): Checklist and Explanation. Ann Intern Med 2018; 169(7): 467-73. https://doi.org/10.7326/m18-0850
10. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021; 372: n71. https://doi.org/10.1136/bmj.n71
11. Ammori JB, Sigakis M, Englesbe MJ, O’Reilly M, Pelletier SJ. Effect of intraoperative hyperglycemia during liver transplantation. J Surg Res 2007; 140(2): 227-33. https://doi.org/10.1016/j.jss.2007.02.019
12. Wallia A, Parikh ND, Molitch ME, Mahler E, Tian L, Huang JJ, et al. Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation 2010; 89(2): 222-6. https://doi.org/10.1097/tp.0b013e3181c3c2ff
13. Builes Montaño CE, Montoya JF, Aguiar Londoño C, Palacios Bayona KL, Restrepo Gutiérrez JC, Gutiérrez Restrepo J, et al. Complicaciones asociadas a la hiperglucemia en pacientes trasplantados de hígado. Rev Gastroenterol Mex 2014; 79(3): 180-6. https://doi.org/10.1016/j.rgmxen.2014.08.004
14. Blasi A, Beltran J, Martin N, Martinez-Pallí G, Lozano JJ, Balust J, et al. Transient hyperglycemia during liver transplantation does not affect the early graft function. Ann Hepatol 2015; 14(5): 675-87. https://doi.org/10.1016/S1665-2681(19)30762-8
15. Katsura E, Ichikawa T, Taura N, Miyaaki H, Miuma S, Shibata H, et al. Elevated fasting plasma glucose before liver transplantation is associated with lower post-transplant survival. Med Sci Monit 2016; 22: 4707-15. https://doi.org/10.12659/MSM.897925
16. Ramos-Prol A, Hervás-Marín D, Rodríguez-Medina B, Rubio-Almanza M, Berenguer M, Moya-Herraiz Á, et al. Intensified blood glucose treatment in diabetic patients undergoing a liver transplant: impact on graft evolution at 3 months and at 5 years. J Endocrinol Invest 2018; 41(7): 821-9. https://doi.org/10.1007/s40618-017-0810-z
17. Ke QH, Huang HT, Ling Q, Liu JM, Dong SY, He XX, et al. New-onset hyperglycemia immediately after liver transplantation: A national survey from China Liver Transplant Registry. Hepatobiliary Pancreat Dis Int 2018; 17(4): 310-5. https://doi.org/10.1016/j.hbpd.2018.08.005
18. Giráldez E, Varo E, Guler I, Cadarso-Suarez C, Tomé S, Barral P, et al. Post-operative stress hyperglycemia is a predictor of mortality in liver transplantation. Diabetol Metab Syndr 2018; 10:35. https://doi.org/10.1186/s13098-018-0334-5
19. Kalaitzakis E, Rosengren A, Skommevik T, Björnsson E. Coronary artery disease in patients with liver cirrhosis. Dig Dis Sci 2010; 55(2): 467-75. https://doi.org/10.1007/s10620-009-0738-z
20. McAvoy NC, Kochar N, McKillop G, Newby DE, Hayes PC. Prevalence of coronary artery calcification in patients undergoing assessment for orthotopic liver transplantation. Liver Transplant 2008; 14(12): 1725-31. https://doi.org/10.1002/lt.21540
21. Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C, et al. Microvascular complications in cystic fibrosisrelated diabetes. Diabetes Care 2007; 30(5): 1056-61. https://doi.org/10.2337/dc06-1576
22. Oggianu L, Lancellotti S, Pitocco D, Zaccardi F, Rizzo P, Martini F, et al. The oxidative modification of von Willebrand factor is associated with thrombotic angiopathies in diabetes mellitus. PLoS ONE 2013; 8(1): e55396. https://doi.org/10.1371/journal.pone.0055396
23. Perseghin G, Mazzaferro V, Sereni LP, Regalia E, Benedini S, Bazzigaluppi E, et al. Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: Effect of liver transplantation. Hepatology 2000; 31(3): 694-703. https://doi.org/10.1002/hep.510310320
24. Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, et al. The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes. Crit Care Med 2011; 39(1):105-11. https://doi.org/10.1097/ccm.0b013e3181feb5ea
25. Cano N. Inter-relationships between renal metabolism (both in physiology and renal dysfunction) and the liver. Curr Opin Clin Nutr Metab Care 2001; 4(4): 279-85. https://doi.org/10.1097/00075197-200107000-00006
26. Park C, Hsu C, Neelakanta G, Nourmand H, Braunfeld M, Wray C, et al. Severe intraoperative hyperglycemia is independently associated with surgical site infection after liver transplantation. Transplantation 2009; 87(7):1031-6. https://doi.org/10.1097/tp.0b013e31819cc3e6
27. Roccaro GA, Goldberg DS, Hwang WT, Judy R, Thomasson A, Kimmel SE, et al. Sustained posttransplantation diabetes is associated with long-term major cardiovascular events following liver transplantation. Am J Transplant 2018; 18(1): 207-15. https://doi.org/10.1111/ajt.14401
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Manuela Izidio de Lima, Djalma da Silva Cavalcanti Filho , Gabriel Henrique Gomes e Silva, José Henrique da Silva, José Vitor Lins Ferreira, Marcelo Irineu de Moura Freire, Rafael Eduardo Correntesa de Almeida, Victor Presto de Oliveira Macedo, Hugo Rafael de Souza e Silva, Olival Cirilo Lucena da Fonseca Neto
This work is licensed under a Creative Commons Attribution 4.0 International License.
